Alendronate/Colecalciferol: A Viewpoint by Michael Kleerekoper and Aysegul Atmaca

By Kleerekoper Michael   Atmaca Aysegul  

Treatments in Endocrinology, Vol. 4, Iss. 6, 2005-01 ,pp. : 379-379

Adis International

Access to resources Recommend Favorite

Alendronate for the Treatment of Osteoporosis in Men

By Adami S.   Prizzi R.   Colapietro F.  

Calcified Tissue International, Vol. 69, Iss. 4, 2001-10 ,pp. : 239-241

Springer Publishing Company

Access to resources Recommend Favorite

Persistence of weekly alendronate: a real-world study in Croatia

By Grazio Simeon   Babic-Naglic Durda   Kehler Tatjana   Curkovic Bozidar  

Clinical Rheumatology, Vol. 27, Iss. 5, 2008-05 ,pp. : 651-653

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Risk of Upper Gastrointestinal Tract Events in Risedronate Users Switched to Alendronate

By Ralston Stuart  

Calcified Tissue International, Vol. 87, Iss. 6, 2010-12 ,pp. : 550-550

Springer Publishing Company

Access to resources Recommend Favorite

Characteristics Associated with Bone Mineral Density Responses to Alendronate in Men

By Swenson Erik  

Calcified Tissue International, Vol. 92, Iss. 6, 2013-06 ,pp. : 548-556

Springer Publishing Company

Access to resources Recommend Favorite